阅读说明：本技术 包含磷酸肌醇3-激酶抑制剂和第二抗增殖剂的组合物 (Compositions comprising phosphoinositide 3-kinase inhibitors and second antiproliferative agents ) 是由 斯蒂芬·约瑟夫·沙特勒沃斯 安德鲁·大卫·惠尔 于 2016-08-19 设计创作，主要内容包括：本发明涉及药物组合物,包含式(I)的化合物或其药物可接受的盐以及至少一种第二试剂的组合,所述第二试剂选自信号传导途径抑制剂、肿瘤免疫治疗剂、抑制BCL2家族蛋白的试剂、抑制Mcl-1的试剂、蛋白酶体抑制剂、聚(ADP-核糖)聚合酶(PARP)抑制剂、芳香化酶抑制剂、常规细胞毒性试剂或选自阿比特龙、ARN-509和MYC抑制剂的其他试剂。(The present invention relates to a pharmaceutical composition comprising a combination of a compound of formula (I) or a pharmaceutically acceptable salt thereof and at least one second agent selected from the group consisting of a signaling pathway inhibitor, a tumor immunotherapeutic agent, an agent that inhibits a BCL2 family protein, an agent that inhibits Mcl-1, a proteasome inhibitor, a poly (ADP-ribose) polymerase (PARP) inhibitor, an aromatase inhibitor, a conventional cytotoxic agent or another agent selected from abiraterone, ARN-509 and a MYC inhibitor.)